electroCore Past Earnings Performance
Past criteria checks 0/6
electroCore has been growing earnings at an average annual rate of 21.8%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 43.9% per year.
Key information
21.8%
Earnings growth rate
43.8%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 43.9% |
| Return on equity | -253.1% |
| Net Margin | -117.5% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
electroCore sees Q3 revenue below consensus
Oct 14electroCore is issued 4 new U.S. patents in nVNS therapy
Sep 21electroCore sees Q2 revenue estimate higher than consensus
Jul 12We Think electroCore (NASDAQ:ECOR) Can Afford To Drive Business Growth
Apr 29
electroCore: Pioneering Bioelectronic Medicine
Jan 06electroCore completes sale of $1.4M of NOL tax benefits
Jun 09Do Institutions Own electroCore, Inc. (NASDAQ:ECOR) Shares?
Feb 19
electroCore expects FY20 revenue at upper end of $3.3M to $3.5M
Jan 11electroCore (NASDAQ:ECOR) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Jan 07electroCore gains on distribution deal for gammaCore Sapphire in Eastern Europe
Dec 22electroCore shares jump 9% on positive results in migraine prevention study
Dec 08electroCore (ECOR) Investor Presentation - Slideshow
Nov 20Revenue & Expenses BreakdownBeta
How electroCore makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 16 | -19 | 27 | 5 |
| 30 Sep 23 | 13 | -21 | 26 | 6 |
| 30 Jun 23 | 11 | -22 | 25 | 6 |
| 31 Mar 23 | 9 | -22 | 25 | 6 |
| 31 Dec 22 | 9 | -22 | 24 | 6 |
| 30 Sep 22 | 8 | -21 | 24 | 5 |
| 30 Jun 22 | 7 | -20 | 23 | 3 |
| 31 Mar 22 | 6 | -17 | 22 | 3 |
| 31 Dec 21 | 5 | -17 | 22 | 3 |
| 30 Sep 21 | 5 | -19 | 21 | 3 |
| 30 Jun 21 | 4 | -19 | 21 | 3 |
| 31 Mar 21 | 4 | -21 | 21 | 3 |
| 31 Dec 20 | 3 | -24 | 22 | 4 |
| 30 Sep 20 | 3 | -26 | 24 | 5 |
| 30 Jun 20 | 3 | -32 | 27 | 6 |
| 31 Mar 20 | 3 | -39 | 31 | 8 |
| 31 Dec 19 | 2 | -45 | 35 | 10 |
| 30 Sep 19 | 2 | -52 | 41 | 12 |
| 30 Jun 19 | 2 | -55 | 44 | 12 |
| 31 Mar 19 | 1 | -49 | 47 | 14 |
| 31 Dec 18 | 1 | -35 | 43 | 12 |
| 30 Sep 18 | 1 | -19 | 36 | 10 |
| 30 Jun 18 | 1 | -6 | 29 | 10 |
| 31 Mar 18 | 1 | 6 | 22 | 8 |
| 31 Dec 17 | 1 | 0 | 18 | 8 |
| 31 Dec 16 | 0 | -16 | 7 | 8 |
Quality Earnings: ECOR is currently unprofitable.
Growing Profit Margin: ECOR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ECOR is unprofitable, but has reduced losses over the past 5 years at a rate of 21.8% per year.
Accelerating Growth: Unable to compare ECOR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ECOR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: ECOR has a negative Return on Equity (-253.08%), as it is currently unprofitable.